Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 4,585.00
-85.00 (-1.82%)
At close: May 20, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 105.77 billion as of May 21, 2026. Its market cap has decreased by -0.33% in one year.
Market Cap
105.77B
Enterprise Value
90.97B
Revenue
26.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,585.00
Market Cap Chart
Since November 22, 2018, Cytogen's market cap has increased from 87.89B to 105.77B, an increase of 20.35%. That is a compound annual growth rate of 2.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 105.77B | -49.00% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XEXYMIX | 109.80B |
| Sewoon Medical | 109.09B |
| NFC Corporation | 108.97B |
| The Nature Holdings | 108.50B |
| Viatron Technologies | 108.35B |
| Foodnamoo. | 108.00B |
| Organoidsciences | 107.87B |
| Aminologics | 106.36B |